About The Medical Condition EN-1639A
Find the definition of the medical term EN-1639A. EN-1639A defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
EN-1639A
| EN-1639A Medical Condition |
|---|
What's The Definition Of The Medical Condition EN-1639A?
Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Theory, Jungian ‐ A theoretical psychoanalytical system centered around symbols…
- American, Chinese ‐ Persons living in the United States having origins in any of…
- Muscles, Palatal ‐ The muscles of the palate are the glossopalatine, palatoglossus,…
- Amstelodamensis, Typus Degenerativus ‐ A syndrome characterized by growth retardation, severe MENTAL…
- Fenestration, Labyrinth ‐ The surgical creation of a new opening in the labyrinth of the…
- Syndrome, Aortitis ‐ Any of a group of disorders leading to occlusion of the arteries…
- Posterior Fossa Tumors ‐ Intracranial tumors originating in the region of the brain inferior…
- Naloxone Hydrobromide ‐ A specific opiate antagonist that has no agonist activity. It…
- Glucose Transport Protein ‐ Membrane transport proteins which bind glucose and sodium ions…
- Complement Inactivators ‐ Serum proteins which act at key sites in the complement sequence…